ScinoPharm Taiwan LtdScinoPharm Taiwan Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Other corporations in the rating industry group for ScinoPharm Taiwan Ltd are shown. This ESG rating covers 17 United Nations SDGs including: 'Clean Water & Sanitation', 'Climate Action' and 'Life on Land'. This analysis of ScinoPharm Taiwan Ltd uses data from across the web as well as from public filings by ScinoPharm Taiwan Ltd.

ScinoPharm Taiwan Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.

SDG Transparency Score for ScinoPharm Taiwan Ltd 
Low
0 - 3
Medium
4 - 6

8.0

High Impact
7 - 10
Last Score Update: 2023-07-01
What drives the score for ScinoPharm Taiwan Ltd 
8.0

Environmental

8.0

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
36Repligen Corp
8.1
High
36Zealand Pharma A/S
8.1
High
55ScinoPharm Taiwan Ltd
8.0
High
55Abbott India Ltd
8.0
High
55Amrutanjan Health Care Ltd
8.0
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does ScinoPharm Taiwan Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd offer flexible work?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose water use targets?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did ScinoPharm Taiwan Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has ScinoPharm Taiwan Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is ScinoPharm Taiwan Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose its waste policy?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose energy use targets?

LockedSign up for free to unlock

Does ScinoPharm Taiwan Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does ScinoPharm Taiwan Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for ScinoPharm Taiwan Ltd
These potential risks are based on the size, segment and geographies of the company.

ScinoPharm Taiwan, Ltd., together with its subsidiaries, researches and develops, produces, and sells cGMP active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, the United States, Europe, India, rest of Asia, and internationally. The company offers custom synthesis services for biochemistry molecules, such as peptides and nucleic acids; generic API manufacturing services; and outsourcing services. It also provides CRAM services, such as chemistry skill, analytical and regulatory, chemical process development, clinical drug substance, and consulting services for the development and manufacturing of clinical, small-scale, and commercial-stage APIs and intermediates. In addition, the company develops peptide synthesis technologies. Further, it develops and manufactures western medicines and other chemical materials, albumin medicines, oligonucleotide medicines, injections, and new small molecule drugs, as well as provides biological technology services and technical services. It has a strategic alliance with Baxter International Inc. to develop, manufacture, and commercialize of antiemetic drug in chemotherapy for cancer. ScinoPharm Taiwan, Ltd. was incorporated in 1997 and is headquartered in Tainan City, Taiwan.

Sorry!

Failed to process!